Corrigan Financial, Inc. Bristol Myers Squibb CO Transaction History

Corrigan Financial, Inc.

$436 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 01, 2023	BUY	$63.71 - $70.74 $63 - $70	1 Added 0.02%	4,862 $311 Million
Q1 2023 Sep 01, 2023	BUY	$65.71 - $74.53 $65 - $74	1 Added 0.02%	4,861 $337 Million
Q4 2022 Sep 01, 2023	SELL	$68.48 - $81.09 $2,465 - $2,919	-36 Reduced 0.74%	4,860 $350 Million
Q3 2022 Sep 01, 2023	BUY	$0.13 - $76.84 $22 - $13,370	174 Added 3.68%	4,896 $348 Million
Q2 2022 Sep 01, 2023	BUY	$72.62 - $79.98 $72 - $79	1 Added 0.02%	4,722 $364 Million
Q1 2022 Sep 01, 2023	BUY	$61.48 - $73.72 $61 - $73	1 Added 0.02%	4,721 $345 Million
Q4 2021 Sep 01, 2023	BUY	$53.63 - $62.52 $107 - $125	2 Added 0.04%	4,720 $294 Million
Q3 2021 Sep 01, 2023	BUY	$59.17 - $69.31 $59 - $69	1 Added 0.02%	4,718 $279 Million
Q2 2021 Sep 01, 2023	SELL	$61.91 - $67.42 $6,376 - $6,944	-103 Reduced 2.14%	4,717 $315 Million
Q1 2021 Sep 01, 2023	SELL	$59.34 - $66.74 $5,993 - $6,740	-101 Reduced 2.05%	4,820 $304 Million
Q4 2020 Sep 01, 2023	BUY	$57.74 - $65.43 $32,276 - $36,575	559 Added 12.82%	4,921 $305 Million
Q3 2020 Sep 01, 2023	BUY	$57.43 - $63.64 $114 - $127	2 Added 0.05%	4,362 $263 Million
Q2 2020 Sep 01, 2023	SELL	$54.82 - $64.09 $21,818 - $25,507	-398 Reduced 8.36%	4,360 $256 Million
Q1 2020 Sep 01, 2023	BUY	$46.4 - $67.43 $92 - $134	2 Added 0.04%	4,758 $265 Million
Q4 2019 Sep 01, 2023	BUY	$49.21 - $64.19 $5,314 - $6,932	108 Added 2.32%	4,756 $305 Million
Q3 2019 Sep 01, 2023	BUY	$42.77 - $50.71 $85 - $101	2 Added 0.04%	4,648 $236 Million
Q2 2019 Sep 01, 2023	SELL	$44.62 - $49.34 $102,492 - $113,333	-2,297 Reduced 33.08%	4,646 $211 Million
Q1 2019 Aug 31, 2023	BUY	$45.12 - $53.8 $101,023 - $120,458	2,239 Added 47.6%	6,943 $331 Million
Q4 2018 Aug 31, 2023	BUY	$48.76 - $63.23 $12,092 - $15,681	248 Added 5.57%	4,704 $245 Million
Q3 2018 Aug 31, 2023	SELL	$55.19 - $62.25 $16,391 - $18,488	-297 Reduced 6.25%	4,456 $277 Million
Q2 2018 Aug 31, 2023	BUY	$50.53 - $62.98 $202 - $251	4 Added 0.08%	4,753 $263 Million
Q1 2018 Aug 31, 2023	BUY	$59.92 - $68.98 $179 - $206	3 Added 0.06%	4,749 $300 Million
Q4 2017 Aug 31, 2023	BUY	$59.94 - $65.35 $7,132 - $7,776	119 Added 2.57%	4,746 $291 Million
Q3 2017 Aug 31, 2023	BUY	$55.23 - $63.74 $5,854 - $6,756	106 Added 2.34%	4,627 $295 Million
Q2 2017 Aug 31, 2023	BUY	N/A	4,521 New	4,521 $252 Million
Q2 2016 Aug 30, 2023	BUY	N/A	38 Added 1.27%	3,019 $222 Million
Q4 2015 Aug 30, 2023	BUY	N/A	2,981	2,981 $0

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrigan Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corrigan Financial, Inc. with notifications on news.

Account